Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/01/2005US20050266422 Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides
12/01/2005US20050266421 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/01/2005US20050266416 Molecular nanomotor
12/01/2005US20050266406 Maxs as modifiers of the axin pathway and methods of use
12/01/2005US20050266402 Compositions and methods for binding agglomeration proteins
12/01/2005US20050266401 Compositions and methods for binding agglomeration proteins
12/01/2005US20050266397 Methods for identification of coronaviruses
12/01/2005US20050266093 Nanogene therapy for cell proliferation disorders
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance
12/01/2005US20050266026 Multi plasmid system for the production of influenza virus
12/01/2005US20050266025 Novel use
12/01/2005US20050266024 Adjuvant
12/01/2005US20050266020 Modular transport systems for molecular substances and production and use thereof
12/01/2005US20050266017 Plasmodium falciparum antigens inducing protective antibodies
12/01/2005US20050266013 Diagnosis of RH factor; using polypeptides to form antibodies; purified polypeptide capable of forming antigen binding structures with specificity for Rhesus D antigens for treating idiopathic thrombocytopenic purpura (ITP) or mistransfusion of Rhesus incompatible blood
12/01/2005US20050266003 Antibodies and their derivatives that induce apoptosis upon binding to P-Selectin Glycoprotein Ligand-1 (PSGL-1) on activatedT cells; autoimmune diseases, transplant rejection, antiallergens, and T cell-derived cancers, anticarinogenic agents;immunosuppressants; induction of immunological tolerance
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265997 Cancer treatment method by inhibiting MAGE gene expression or function
12/01/2005US20050265988 Glycosylated glucocerebrosidase expression in fungal hosts
12/01/2005US20050265987 Sulfatases and methods of use thereof
12/01/2005US20050265983 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
12/01/2005US20050265978 Muscle-derived cells (MDCs) for treating muscle- or bone-related injury or dysfunction
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005US20050265975 Method for selective inactivation of viral replication
12/01/2005US20050265974 Recombinant viral-based malaria vaccines
12/01/2005US20050265973 Chimeric adenoviruses for use in cancer treatment
12/01/2005US20050265972 A genetic construct containing a glucose inducible regulatory element with a pair of CACGTG nucleotide sequences and confer human proinsulin expression in host hepatocyte cells; therapy for diabetes
12/01/2005US20050265971 Agent for treatment of breast cancer and pancreatic cancer comprising herpes simplex virus mutant
12/01/2005US20050265967 Interferon-alpha induced gene
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005US20050265961 Biodegradable poly(beta-amino esters) and uses thereof
12/01/2005US20050265927 Intranasal delivery of nucleic acid molecules
12/01/2005US20050262765 Floral packaging material having great masters prints thereon
12/01/2005DE10328669B4 Plasmidfreier Klon des E. coli Stammes DSM 6601 Plasmid-free clone of E. coli strain DSM 6601
12/01/2005DE102004052254A1 Verfahren zum Aufschluss von Zellen und zur Abtrennung von Zellbestandteilen A method of cell disruption and separation of cell components
12/01/2005DE102004023187A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy
12/01/2005DE102004021584A1 New viral vector particle comprising capsid proteins comprising an attachment site comprising cysteine residue, useful in preparing a composition for treating e.g., tumor
12/01/2005DE102004017141A1 Neue Gene aus Biosynthese Genclustern zur Synthese von Aminoglycosid-Antibiotika sowie damit herstellbare neue Aminoglycosid-Antibiotika New genes from biosynthesis gene clusters for the synthesis of aminoglycoside antibiotics and thus producible new aminoglycoside antibiotics
12/01/2005DE10000629B4 Verfahren zur Identifizierung einer auf einen festen Körper aufgebrachten Markierung A method for identifying an applied onto a solid body label
12/01/2005CA2824701A1 Modulation of glucose-6-phosphate translocase expression
12/01/2005CA2797972A1 Maize multidrug resistance-associated protein polynucleotides and methods of use
12/01/2005CA2572446A1 Combinatorial selection of phosphorothioate aptamers for tgf-beta
12/01/2005CA2569272A1 Promotion of somatic embryogenesis in plants by pga37 gene expression
12/01/2005CA2567650A1 A probe for detection and quantification of inositol-1,4,5-trisphosphateand a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same
12/01/2005CA2567563A1 Thermostable y-family polymerases and chimeras
12/01/2005CA2567501A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005CA2567496A1 C1q family member proteins with altered immunogenicity
12/01/2005CA2567455A1 Adenovirus/alphavirus hybrid vector for the effective administration and expression of therapeutic genes in tumour cells
12/01/2005CA2567366A1 Methods for production of xylitol in microorganisms
12/01/2005CA2567272A1 Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production
12/01/2005CA2567251A1 Multiple transcription unit systemes, vectors and host cells containing them, and methods of making and using them
12/01/2005CA2566949A1 Polynucleotides for the detection of escherichia coli o157:h7 and escherichia coli o157:nm verotoxin producers
12/01/2005CA2566903A1 Modified antigen-presenting cells
12/01/2005CA2566462A1 Compositions and methods for sirna inhibition of primate polyomavirus genes
12/01/2005CA2566439A1 Methods of preventing and treating alimentary mucositis
12/01/2005CA2565300A1 Fgf-21 fusion proteins
12/01/2005CA2564770A1 Chimeric soluble hyper il-11 and use thereof
12/01/2005CA2564311A1 Nucleic acid ligands specific to immunoglobulin e and their use as atopic disease therapeutics
12/01/2005CA2564217A1 Aptamer-nanoparticle conjugates and method of use for target analyte detection
12/01/2005CA2563801A1 Modulation of glucose-6-phosphatase translocase expression
12/01/2005CA2562911A1 Expression cassette
12/01/2005CA2562482A1 Novel gene disruptions, compositions and methods relating thereto
11/2005
11/30/2005EP1600512A1 mRNA purification on microplates
11/30/2005EP1600510A2 DNA sequences having anti-repressor activity
11/30/2005EP1600509A1 Transgenic plant having fructooligosaccharide accumulated therein and process for constructing the same
11/30/2005EP1600507A1 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same
11/30/2005EP1600506A2 Oligoribonucleotides and ribonucleases for cleaving RNA
11/30/2005EP1600505A1 Escherichia coli phytase
11/30/2005EP1600503A1 Modified pyrroloquinoline quinone-dependent glucose dehydrogenase
11/30/2005EP1600499A1 Process for producing lactonase and utilization thereof
11/30/2005EP1600459A2 Ligand
11/30/2005EP1600452A2 Synthesis of 2'-deoxy-L-nucleosides
11/30/2005EP1600451A2 Synthesis of 2'-deoxy-l-nucleosides
11/30/2005EP1599605A1 Screening method for genes of brewing yeast
11/30/2005EP1599604A2 Methods and tools for screening active rna in cellulo
11/30/2005EP1599596A2 Combinatorial dna library for producing modified n -glycans in lower eukaryotes
11/30/2005EP1599595A2 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/30/2005EP1599593A2 Use of a tricyclic antidepressant drug for promoting endocytosis
11/30/2005EP1599592A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins
11/30/2005EP1599591A2 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor
11/30/2005EP1599590A2 Modified low molecular weight glutenin with reduced risk to patients with celiak disease
11/30/2005EP1599589A1 Enhanced expression of fusion polypeptides with a biotinylation tag
11/30/2005EP1599588A2 Dna molecules encoding a cotton chitinase and promoter
11/30/2005EP1599587A2 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
11/30/2005EP1599586A2 Rna-interference for znfn3a1-gene as a method for inhibiting cancer cell growth
11/30/2005EP1599584A1 Modified nitrilases and their use in methods for the production of carboxylic acids
11/30/2005EP1599582A2 Method for the production of polyunsaturated fatty acids
11/30/2005EP1599581A2 Production of a live vaccine directed against influenza viruses
11/30/2005EP1599579A1 Translocating enzyme used as a selection marker
11/30/2005EP1599578A2 Methods for preventing gluconoylation of proteins
11/30/2005EP1599577A2 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response, tamoxifen resistance and metastasis
11/30/2005EP1599573A2 Model for studying the role of genes in tumor resistance to chemotherapy
11/30/2005EP1599497A2 Crystal structure of the ternary compelex of 14-3-3, fusicoccin, and plasma membrane atpase and methods for designing new herbicides
11/30/2005EP1599495A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
11/30/2005EP1599489A1 Method of isolating nucleic acids from stool samples
11/30/2005EP1599278A2 Method of producing a carbohydrate ester, a protein ester, a protein subunit ester or a hydroxy acid ester
11/30/2005EP1599231A2 Treatment of pain through expression of opioid receptors
11/30/2005EP1599230A1 Process for generating multilayered particles
11/30/2005EP1599168A2 Relaxin3-gpcr135 complexes and their production and use
1 ... 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 ... 4023